Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 517 entries
View as:

A Phase 1, Randomized, Placebo-controlled, Single & Multiple Dose Escalation Study to Investigate Safety, Pharmacokinetics, and Pharmacodynamics of SHR0534 in Healthy Chinese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02750553 Org: User:
Start: 01/31/15 End: - Due: -

Identify Effective Doses of SHR7280 Tablets in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted Reproductive Technology (ART)

Phase: N/A Priority: Normal
NCT ID: NCT05082233 Org: User:
Start: 03/06/22 End: 08/03/23 Due: 08/03/24

A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03863223 Org: User:
Start: 04/22/19 End: 07/30/24 Due: 07/30/25

A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor

Phase: N/A Priority: Normal
NCT ID: NCT02336724 Org: User:
Start: 03/31/12 End: 06/30/19 Due: 06/30/20

A Study of Linperlisib (YY-20394) in Combination With Rituximab in Patients With Relapsed/Refractory Indolent NHL

Phase: N/A Priority: Normal
NCT ID: NCT06981988 Org: User:
Start: 06/30/25 End: 02/28/27 Due: 02/28/28

A Trial of SHR-1701 With or Without Famitinib in Patients With Advanced or Metastatic NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04699968 Org: User:
Start: 01/15/21 End: 11/15/21 Due: 11/15/22

Effect of Itraconazole on the Pharmacokinetics of Pyrotinib in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04479891 Org: User:
Start: 09/18/19 End: 11/30/19 Due: 11/30/20

A Phase III Study of SP2086 in Combination With Metformin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01970046 Org: User:
Start: 04/30/13 End: 01/31/15 Due: 01/31/16

A Study of SHR-4394 Injection in Subjects With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06783829 Org: User:
Start: 01/22/25 End: 03/31/27 Due: 03/31/28

A Study for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions

Phase: N/A Priority: Normal
NCT ID: NCT06731829 Org: User:
Start: 12/31/24 End: 04/30/25 Due: 04/30/26

To Compare the Efficacy and Safety of BP102 vs. Avastin® in Combination With Paclitaxel/Carboplatin in First-line Treatment of Advanced or Relapsed NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT05169801 Org: User:
Start: 01/25/18 End: 06/17/21 Due: 06/17/22

Effect of Itraconazole on the Pharmacokinetics of SHR6390 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04423601 Org: User:
Start: 06/10/20 End: 02/02/21 Due: 02/02/22

A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01611051 Org: User:
Start: 03/31/12 End: - Due: -

An Investigational Study of SHR6390 in Participants With Mild to Moderate Liver Impairment and Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04631575 Org: User:
Start: 12/31/20 End: 03/31/21 Due: 03/31/22

A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04300114 Org: User:
Start: 08/19/20 End: 02/18/22 Due: 02/18/23

Drug Interaction Between SHR4640 Tablets and Furosemide Tablets in Healthy Volunteers (Single Center, Single Arm, Open, Self-control)

Phase: N/A Priority: Normal
NCT ID: NCT04850638 Org: User:
Start: 06/28/21 End: 09/14/21 Due: 09/14/22

A Study of SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPC

Phase: N/A Priority: Normal
NCT ID: NCT03741712 Org: User:
Start: 11/20/18 End: 12/08/20 Due: 12/08/21

A Drug-drug Interaction Study of SHR6390 on Healthy Chinese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04973020 Org: User:
Start: 09/01/21 End: 10/28/21 Due: 10/28/22

A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03520478 Org: User:
Start: 05/30/18 End: 04/30/25 Due: 04/30/26

A Study of Remimazolam Tosilate for Sedation in Non-intubated Diagnostic and Therapeutic Procedures

Phase: N/A Priority: Normal
NCT ID: NCT06216444 Org: User:
Start: 01/31/24 End: 03/31/24 Due: 03/31/25

Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib in the Treatment of Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01531777 Org: User:
Start: 04/30/11 End: 11/30/14 Due: 11/30/15

A Trial of HR18034 in Inguinal Hernia Repair

Phase: N/A Priority: Normal
NCT ID: NCT04551924 Org: User:
Start: 10/01/20 End: 05/30/21 Due: 05/30/22

A Trial of Hetrombopag in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05088174 Org: User:
Start: 09/03/20 End: 10/22/20 Due: 10/22/21

A Trial of HRS-8427 in the Treatment of Adults With Complicated Urinary Tract Infection, Including Acute Pyelonephritis

Phase: N/A Priority: Normal
NCT ID: NCT06569056 Org: User:
Start: 09/25/24 End: 11/30/25 Due: 11/30/26

Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer. (PHOEBE)

Phase: N/A Priority: Normal
NCT ID: NCT03080805 Org: User:
Start: 05/03/17 End: 03/31/21 Due: 03/31/22